Oxford Instruments PLC
26 September 2006
26 September 2006
Oxford Instruments plc: Chairman's AGM Statement - 2006
Oxford Instruments plc is holding its Annual General Meeting today at which the
Chairman, Nigel Keen, will make the following statement :
"Last year we laid out our strategic agenda and defined our aim to exploit the
Group's technology to become the leading provider of a new generation of tools
and systems for work at the atomic and molecular level in the physical and
bioscience sectors. In order to implement this strategy we have, as previously
announced, increased our R & D spend. In addition, we have refocused the
business towards the commercial realisation of transforming nanoscience into its
applications. Increasingly, we provide total solutions to end-users and
differentiate our products by both technical excellence and customer service.
We have stepped up our programme of product introductions. The HyperSense
Dynamic Nuclear Polarisation product launched earlier in the year has generated
significant customer interest. HyperSense has the potential to revolutionise
many analytical applications including the development of new pharmaceuticals.
Two other major new products have been introduced in the year together with a
number of upgrades of our existing product line to ensure our products maintain
their leading positions.
Our new commercial approach is also yielding benefits, with significant new
orders obtained from customers in Europe, North America and the Far East.
Current Trading
Order levels and turnover for the year to date are ahead of the company's
expectations. Following the closure of our undifferentiated NMR Magnet Business,
the cost savings predicted in March this year are being realised. The post
closure issues are being resolved and the on-site work needed to meet customer
specification requirements in the bespoke magnet business continues.
Despite the impact of unusually adverse dollar movements and the increase in the
price of copper, which have affected us in recent months, the trading results of
the half-year are expected to be better than at the same point last year, in
line with the company's expectations.
Oxford Instruments plc Tel: 01865 881437 Fax: 01865 884045
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director
Hogarth Partnership Limited Tel: 020 7357 9477 Fax: 020 7357 8533
Rachel Hirst
Andrew Jaques
Anthony Arthur
Notes to Editors
Oxford Instruments designs, supplies and supports high-technology tools,
processes and solutions with a focus on physical science, bioscience,
environmental and industrial research and applications. It provides solutions
needed to advance fundamental nanoscience research and its transfer into
commercial nanotechnology applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for over 40 years, and its
strategy is to effect the successful commercialisation of these ideas by
bringing them to market in a timely and customer-focused fashion.
The first technology business to be spun out from Oxford University over forty
years ago, Oxford Instruments is now a global company with over 1,300 staff
worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to
be the leading provider of new generation tools and systems for the Physical
Science and Bioscience sectors.
This involves the combination of core technologies in areas such as low
temperature and high magnetic field environments, Nuclear Magnetic Resonance,
X-ray electron and optical based metrology, and advanced growth, deposition and
etching. Our products, expertise, and ideas address global issues such as
energy, environment, terrorism and health and are part of the next generation of
telecommunications, energy products, environmental measures, security devices,
drug discovery and medical advances
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.